Journal of the American Chemical Society · 2010 · 145 citations · 13 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyStructure-activity RelationshipsSynthetic Medicinal ChemistryKidney CancerOncology PharmacologyRenal Cell CarcinomaAnticancer ActivityCancer Cell Proliferation InhibitionMedicinal Chemistry ApplicationsNatural Product Total SynthesisTherapeutic Growth InhibitionTotal Synthesis-derived Analogues
Total synthesis of englerin A, a recently reported sesquiterpenoid exhibiting potent and selective growth inhibition against renal cancer cell lines, has been accomplished. The successful strategy featured a [5 + 2] cycloaddition reaction to cast the seven-membered oxabicyclic key intermediate in both racemic and optically active forms. Synthetic (+/-)-englerin A, (+/-)-englerin B, (+/-)-englerin B acetate, a hydroxy acetate, a tert-butyldimethylsilyl ether, and hydrogenated (+/-)-englerin A (31) were tested for their cytotoxicity against a selected panel of cancer cell lines, and the results are path-pointing to more focused structure-activity relationship studies.
13
N-methoxy-n-methylamides as effective acylating agents
Steven Nahm, Steven M. Weinreb · Tetrahedron Letters · 1981 · 1.8K citations